• 719 Citations
  • 14 Scopus h-Index
20122019
If you made any changes in Pure, your changes will be visible here soon.

Research Output 2012 2019

  • 719 Citations
  • 14 Scopus h-Index
  • 41 Article
  • 12 Review article
  • 10 Letter
  • 3 Comment/debate
Filter
Review article
2018
5 Citations (Scopus)

Clinical presentation of autoimmune and viral encephalitides

Dubey, D., Toledano, M. & McKeon, A., Apr 1 2018, In : Current Opinion in Critical Care. 24, 2, p. 80-90 11 p.

Research output: Contribution to journalReview article

Viral Encephalitis
Clinical Laboratory Techniques
Glial Fibrillary Acidic Protein
Virus Diseases
Encephalitis
2017
5 Citations (Scopus)

B-cell-Targeted therapies in relapsing forms of MS

Dubey, D., Forsthuber, T., Flanagan, E., Pittock, S. J. & Stüve, O., Oct 23 2017, In : Neurology: Neuroimmunology and NeuroInflammation. 4, 6, e405.

Research output: Contribution to journalReview article

Cell- and Tissue-Based Therapy
B-Lymphocytes
Therapeutics
Phase III Clinical Trials
Anti-Idiotypic Antibodies
2 Citations (Scopus)

Gradually progressive spastic ataxia in a young man steadily unsteady

Dubey, D., Khemani, P., Remster, E. & Elliott, J. L., Feb 1 2017, In : JAMA neurology. 74, 2, p. 238-241 4 p.

Research output: Contribution to journalReview article

Neuroimaging
Spinocerebellar Degenerations
Neurologic Examination
Gait
Atrophy
2016
11 Citations (Scopus)

Diagnostic and therapeutic strategies for management of autoimmune encephalopathies

Dubey, D., Blackburn, K., Greenberg, B., Stuve, O. & Vernino, S., Aug 2 2016, In : Expert review of neurotherapeutics. 16, 8, p. 937-949 13 p.

Research output: Contribution to journalReview article

Brain Diseases
Immunomodulation
Nervous System Diseases
Immunotherapy
Early Diagnosis
2 Citations (Scopus)

Managing Disability in Progressive Multiple Sclerosis

Dubey, D., Sguigna, P. & Stüve, O., Jun 1 2016, In : Current Treatment Options in Neurology. 18, 6, 27.

Research output: Contribution to journalReview article

Multiple Sclerosis
ocrelizumab
Comorbidity
Quality of Life
Immunomodulation
17 Citations (Scopus)

Update on monitoring and adverse effects of approved second-generation disease-modifying therapies in relapsing forms of multiple sclerosis

Dubey, D., Cano, C. A. & Stüve, O., Jun 1 2016, In : Current opinion in neurology. 29, 3, p. 278-285 8 p.

Research output: Contribution to journalReview article

Multiple Sclerosis
Progressive Multifocal Leukoencephalopathy
Therapeutics
Antibodies, Monoclonal, Humanized
Relapsing-Remitting Multiple Sclerosis
6 Citations (Scopus)
Cohort Effect
Multiple Sclerosis
Therapeutics
United States Food and Drug Administration
Developing Countries
7 Citations (Scopus)

Use of interleukin-2 for management of natalizumab-associated progressive multifocal leukoencephalopathy: Case report and review of literature

Dubey, D., Zhang, Y., Graves, D., DeSena, A. D., Frohman, E. & Greenberg, B., May 1 2016, In : Therapeutic Advances in Neurological Disorders. 9, 3, p. 211-215 5 p.

Research output: Contribution to journalReview article

Progressive Multifocal Leukoencephalopathy
Interleukin-2
JC Virus
Polymerase Chain Reaction
Cerebrospinal Fluid
2015
39 Citations (Scopus)

Dimethyl fumarate in relapsing-remitting multiple sclerosis: Rationale, mechanisms of action, pharmacokinetics, efficacy and safety

Dubey, D., Kieseier, B. C., Hartung, H. P., Hemmer, B., Warnke, C., Menge, T., Miller-Little, W. A. & Stuve, O., Apr 1 2015, In : Expert review of neurotherapeutics. 15, 4, p. 339-346 8 p.

Research output: Contribution to journalReview article

Relapsing-Remitting Multiple Sclerosis
Multiple Sclerosis
Fumarates
Pharmacokinetics
Safety
8 Citations (Scopus)

Intractable and highly active relapsing multiple sclerosis – Role of alemtuzumab

Dubey, D., Cano, C. A. & Stuve, O., Sep 18 2015, In : Neuropsychiatric Disease and Treatment. 11, p. 2405-2414 10 p.

Research output: Contribution to journalReview article

Multiple Sclerosis
Safety
Antibodies, Monoclonal, Humanized
Phase III Clinical Trials
Graft vs Host Disease
2014
13 Citations (Scopus)

Clinical management of multiple sclerosis and neuromyelitis optica with therapeutic monoclonal antibodies: Approved therapies and emerging candidates

Dubey, D., Kieseier, B. C., Hartung, H. P., Hemmer, B., Miller-Little, W. A. & Stuve, O., Jan 1 2014, In : Expert Review of Clinical Immunology. 11, 1, p. 93-108 16 p.

Research output: Contribution to journalReview article

Neuromyelitis Optica
Multiple Sclerosis
Monoclonal Antibodies
Therapeutics
Neurology
7 Citations (Scopus)

Para-dichlorobenzene toxicity - a review of potential neurotoxic manifestations

Dubey, D., Sharma, V. D., Pass, S. E., Sawhney, A. & Stuve, O., Jan 1 2014, In : Therapeutic Advances in Neurological Disorders. 7, 3, p. 177-187 11 p.

Research output: Contribution to journalReview article

Open Access
Central Nervous System
Leukoencephalopathies
Aromatic Hydrocarbons
Nerve Tissue
4-dichlorobenzene